2-(4-octylphenyl)prop-2-en-1-ol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-octylphenyl)prop-2-en-1-ol
• 化学式: C₁₇H₂₆O
• 分子量: 246.393
• InChiKey: CLGLRIDXJOBWER-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  18
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(4-octylphenyl)prop-2-en-1-ol 、 乙酰乙酸甲酯 在 戴斯-马丁氧化剂 、 aluminium(III) triflate 、 copper(ll) bromide 作用下， 以 二氯甲烷 、 1,4-二氧六环 为溶剂， 反应 4.5h， 以71%的产率得到methyl 4-hydroxy-4’-octyl-[1,1’-biphenyl]-3-carboxylate
  参考文献：
  名称：

  氧化性[3 + 3]环糊精缩醛与1,3-双亲核试剂：一种构造六元芳环的有效方法，包括水杨酸酯和咔唑

  摘要：

  使用N-溴代琥珀酰亚胺或溴化铜（II）作为氧化剂，并使用布朗斯台德酸或路易斯酸作为催化剂，开发了具有各种1,3-双亲核试剂的氧化乙醛缩醛[3 + 3] 。从机械上讲，[3 + 3]圆环可以看作是通过自动串联催化概念建立的氧化试剂诱导的酸-酸催化的多米诺反应。乙酰乙酸烷基酯，α-（吲哚-2-基）乙酸酯，苯胺，1-甲基-1 H-吡唑-3-胺，5-氨基-1 H-吡唑-3-羧酸乙酯和3-氨基-1 H在这种类型的转化中，吲唑都可以用作1,3-双亲核试剂。既定的反应可以非常有效地构建六元芳环，包括水杨酸酯和咔唑。基于氧化性[3 + 3]环化反应，还开发了一种合成抗炎剂二氟乙醛的四步法，收率很高。

  DOI：

  10.1002/adsc.201800462
• 作为产物：
  描述：

  2-氯-2-丙烯-1-醇 、 magnesium,octylbenzene,bromide 在 正丁基锂 、 [1,3-bis(diphenylphosphino)propane]nickel(II) dichloride 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 3.17h， 以71%的产率得到2-(4-octylphenyl)prop-2-en-1-ol
  参考文献：
  名称：

  Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues—Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist

  摘要：

  Compound 1 (FTY720, Fingolimod) represents a new generation of immunosuppressant that modulates lymphocyte trafficking by interacting with the S1P(1) receptor. Compound 1 also provides a template molecule for studying the molecular biology of S1P receptors and related enzymes (kinases and phosphatases). In this study, two conformationally constrained analogues of 1 (3a and 3c) were asymmetrically synthesized in high optical purity. In vitro assessment documented that both analogues are Sphk2 substrates, their phosphorylated species are potent S1P(1) receptor agonists, and 3a-P is a potent SIP3 antagonist. After oral administration in mice, both compounds evoked lymphopenia, but their duration of action differed markedly.

  DOI：

  10.1021/jm7010172

文献信息

• Oxidative [3+3] Annulation of Atropaldehyde Acetals with 1,3‐Bisnucleophiles: An Efficient Method of Constructing Six‐Membered Aromatic Rings, Including Salicylates and Carbazoles
  作者：Yanlong Gu、Fengtian Wu、Jian Yang

  DOI：10.1002/adsc.201800462

  日期：2018.7.16

  Alkyl acetoacetates, α‐(indol‐2‐yl)acetate, anilines, 1‐methyl‐1H‐pyrazol‐3‐amine, ethyl 5‐amino‐1H‐pyrazole‐3‐carboxylate, and 3‐amino‐1H‐indazole can all be used as 1,3‐bisnucleophiles in this type of transformation. The established reactions can very efficiently construct six‐membered aromatic rings, including salicylates and carbazoles. A four‐step method of synthesizing the anti‐inflammatory agent

  使用N-溴代琥珀酰亚胺或溴化铜（II）作为氧化剂，并使用布朗斯台德酸或路易斯酸作为催化剂，开发了具有各种1,3-双亲核试剂的氧化乙醛缩醛[3 + 3] 。从机械上讲，[3 + 3]圆环可以看作是通过自动串联催化概念建立的氧化试剂诱导的酸-酸催化的多米诺反应。乙酰乙酸烷基酯，α-（吲哚-2-基）乙酸酯，苯胺，1-甲基-1 H-吡唑-3-胺，5-氨基-1 H-吡唑-3-羧酸乙酯和3-氨基-1 H在这种类型的转化中，吲唑都可以用作1,3-双亲核试剂。既定的反应可以非常有效地构建六元芳环，包括水杨酸酯和咔唑。基于氧化性[3 + 3]环化反应，还开发了一种合成抗炎剂二氟乙醛的四步法，收率很高。
• Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues—Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist
  作者：Ran Zhu、Ashley H. Snyder、Yugesh Kharel、Lisa Schaffter、Qin Sun、Perry C. Kennedy、Kevin R. Lynch、Timothy L. Macdonald

  DOI：10.1021/jm7010172

  日期：2007.12.13

  Compound 1 (FTY720, Fingolimod) represents a new generation of immunosuppressant that modulates lymphocyte trafficking by interacting with the S1P(1) receptor. Compound 1 also provides a template molecule for studying the molecular biology of S1P receptors and related enzymes (kinases and phosphatases). In this study, two conformationally constrained analogues of 1 (3a and 3c) were asymmetrically synthesized in high optical purity. In vitro assessment documented that both analogues are Sphk2 substrates, their phosphorylated species are potent S1P(1) receptor agonists, and 3a-P is a potent SIP3 antagonist. After oral administration in mice, both compounds evoked lymphopenia, but their duration of action differed markedly.